Health & Territory Research

Of the 3109 greenCOVID participants from Spain, the United Kingdom, and the Republic of Ireland, more than half reported poor well-being (59.0%) and 26.6% indicated a possible presence of clinical depression during the COVID-19 pandemic. This poor well-being was more likely among those who were younger, students, female, physically inactive, with worse home views, and…

EspAax-nr patients are more often female, younger, with longer diagnostic delay and less use of biologic therapy (March 2022)

A total of 634 patients with EspAax and 35 with EspAax-nr belonging to the Atlas of Axial Spondyloarthritis in Spain were analyzed. Compared to patients with EspAax-r, those with EspAax-nr were more frequently female (48.6% vs 91.4%), with longer diagnostic delay (10.1 vs 8.5) and worse psychological health (7.5 vs 5.6). In addition, 20.0% of…

Members of patient organizations with rheumatic diseases receive more information about their disease during pandemic COVID-19 (January 2022)

41.6% of REUMAVID participants were members of patient organizations. Compared to non-members, members received more information during the onset of the COVID pandemic (73.1% vs 40.5% of non-members), as well as greater emotional or psychological support (21.6% vs 9.5% of non-members). Finally, members had better well-being and a lower risk of anxiety. These data are…

During the COVID-19 pandemic, one in four patients with axSpA reported poor health and functioning (January 2022)

Data from 587 axSpA patients who participated in the first phase (April-July 2020) of the REUMAVID study showed that 25.0% had poor health status. In addition, smoking, diabetes, and taking analgesics or corticosteroid use were significantly associated with poor health status, whereas being physically active and being actively employed were inversely associated. This study has…

British patients with rheumatic diseases had better physical and mental health outcomes during the COVID-19 pandemic (December 2021)

At the onset of the pandemic, UK rheumatic disease patients had better well-being, lower disease activity, and lower risk of anxiety and depression. In addition, 81% of UK patients were able to contact their rheumatologist about possible side effects of treatment (vs 57.6% of the other REUMAVID countries). This study is published in the journal…

New article on the impact of axial spondyloarthritis on patients’ working lives in Europe (December 2021)

The scientific manuscript “Patient-reported Impact of Axial Spondyloarthritis on Working Life: Results from the EMAS survey” has been accepted for publication in the journal Arthritis Care & Research. The research, which analyzes data from the International Axial Spondyloarthritis Map (EMAS), focuses on the impact of the disease on the employment status and working conditions of…

60% of patients with axial spondyloarthritis are at risk for mental health disorders (November 2021)

A total of 2166 patients with axial spondyloarthritis belonging to the EMAS study were evaluated. Of these patients, 60.7% reported mental problems, especially in those patients with higher disease activity, with anxiety and depression, those who were unemployed or on sick leave, those with greater functional limitation and younger patients. This study is published in…

Patients with axial spondyloarthritis in Spain present greater diagnostic delay and psychological stress compared to other European patients (July 2021)

A total of 680 patients with axial spondyloarthritis in Spain vs. 2166 with axial spondyloarthritis in 12 European countries were evaluated. With respect to the rest of European patients, Spanish patients showed a longer diagnostic delay (8.5 vs 7.2), higher disease activity (5.7 vs 5.4), and a higher unemployment rate (21.7% vs 9.2%). In addition,…

The results of the first phase of the REUMAVID study were presented on Monday, April 14, 2021 at the British Society for Rheumatology Annual Conference (April 2021)

The results of the first phase of the REUMAVID study were presented on Monday, April 14, 2021 at the British Society for Rheumatology Annual Conference (BSR 2021). The interest raised by the study has led to it being selected for several activities: an ePoster presenting the study data for the UK sample (“Evaluation of the…

Younger age at symptom onset, female gender, higher number of physician visits prior to diagnosis, and being diagnosed by a rheumatologist are associated with longer diagnostic delay in patients with Axial Spondyloarthritis (April 2021)

The diagnostic delay of the 2652 patients belonging to 13 European countries belonging to the European map of axial spondyloarthritis (EMAS) was 7.4 years. Furthermore, this diagnostic delay was associated with younger age at symptom onset, female gender, a higher number of visits to specialists before diagnosis and being diagnosed by a rheumatologist. This study…